Consolidation and construction have long characterized the rapidly growing Atlanta market, which has seen numerous mergers and acquisitions in recent years among both payers and providers. Emory Healthcare ranks first by market share for the first time in years, and Centene—which acquired WellCare in 2020—occupies second-leading payer position, rather than fifth. Power will continue to flux and fuel intensifying negotiations between payers and providers, as well as blurring of payer-provider lines. Although patient volumes continue to wax and wane from COVID-19—which hit Atlanta particularly hard—the outlook for prescription drug utilization and adherence remains high. Atlanta IDNs may make excellent partners on outcomes-based pharmaceutical contracts in the long term, given their clinically integrated network-centric operational models, but they will first need to gain more confidence and experience with risk-based payments.

Related Reports

Harrisburg | Pennsylvania | 2021 | Market Overview Brief

Pittsburgh-based ecosystems UPMC Health and Highmark Health continue to shape the Harrisburg market into another front in their statewide competition. UPMC Pinnacle leads the market’s hosp...

View Details

Cape Coral | Florida | 2021 | Market Overview Brief

Cape Coral health systems are the key drivers in this market and Lee Health and NCH Healthcare—which dominate Lee and Collier counties, respectively—have escalated their rivalry by open...

View Details

Birmingham | Alabama | 2021 | Market Overview Brief

Birmingham, a statewide hub for specialty care, has historically been a slow-moving market from the perspective of value-based contracting. BCBS of Alabama is the power player and key driver of qua...

View Details

Baton Rouge | Louisiana | 2021 | Market Overview Brief

The Baton Rouge market suffers from a high poverty rate and low health literacy, making the populace vulnerable to hospitalization during the COVID-19 pandemic. The market continues to have a scarc...

View Details